These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

928 related articles for article (PubMed ID: 23881695)

  • 1. Topical application of tranexamic acid for the reduction of bleeding.
    Ker K; Beecher D; Roberts I
    Cochrane Database Syst Rev; 2013 Jul; (7):CD010562. PubMed ID: 23881695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranexamic acid for reducing mortality in emergency and urgent surgery.
    Perel P; Ker K; Morales Uribe CH; Roberts I
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD010245. PubMed ID: 23440847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid for patients with nasal haemorrhage (epistaxis).
    Joseph J; Martinez-Devesa P; Bellorini J; Burton MJ
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD004328. PubMed ID: 30596479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrinolytic drugs for acute traumatic injury.
    Ker K; Roberts I; Shakur H; Coats TJ
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD004896. PubMed ID: 25956410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of combined administration of intravenous and topical tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials.
    Xiong H; Liu Y; Zeng Y; Wu Y; Shen B
    BMC Musculoskelet Disord; 2018 Sep; 19(1):321. PubMed ID: 30193586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifibrinolytic drugs for acute traumatic injury.
    Roberts I; Shakur H; Ker K; Coats T;
    Cochrane Database Syst Rev; 2011 Jan; (1):CD004896. PubMed ID: 21249666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
    Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K
    Cochrane Database Syst Rev; 2011 Jan; (1):CD001886. PubMed ID: 21249650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Most Effective Regimen of Tranexamic Acid for Reducing Bleeding and Transfusions in Primary Total Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials.
    Dai WL; Zhou AG; Zhang H; Zhang J
    J Knee Surg; 2018 Aug; 31(7):654-663. PubMed ID: 28895645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of topical tranexamic acid in total hip arthroplasty: a meta-analysis.
    Chen S; Wu K; Kong G; Feng W; Deng Z; Wang H
    BMC Musculoskelet Disord; 2016 Feb; 17():81. PubMed ID: 26878845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical versus intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials.
    Wang S; Gao X; An Y
    Int Orthop; 2017 Apr; 41(4):739-748. PubMed ID: 27837327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmopressin use for minimising perioperative blood transfusion.
    Desborough MJ; Oakland K; Brierley C; Bennett S; Doree C; Trivella M; Hopewell S; Stanworth SJ; Estcourt LJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD001884. PubMed ID: 28691229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic Topical Tranexamic Acid Versus Placebo in Surgical Patients: A Systematic Review and Meta-analysis∗.
    Teoh WY; Tan TG; Ng KT; Ong KX; Chan XL; Hung Tsan SE; Wang CY
    Ann Surg; 2021 Apr; 273(4):676-683. PubMed ID: 32282377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
    Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K
    Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD001886. PubMed ID: 21412876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifibrinolytic drugs for acute traumatic injury.
    Roberts I; Shakur H; Ker K; Coats T;
    Cochrane Database Syst Rev; 2012; 12():CD004896. PubMed ID: 23418644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of combined intravenous and topical administration of tranexamic acid with intravenous tranexamic acid alone for blood loss reduction after total hip arthroplasty: A meta-analysis.
    Liu X; Liu J; Sun G
    Int J Surg; 2017 May; 41():34-43. PubMed ID: 28336258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods to decrease blood loss and transfusion requirements for liver transplantation.
    Gurusamy KS; Pissanou T; Pikhart H; Vaughan J; Burroughs AK; Davidson BR
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD009052. PubMed ID: 22161443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tranexamic acid for upper gastrointestinal bleeding.
    Gluud LL; Klingenberg SL; Langholz E
    Cochrane Database Syst Rev; 2012 Jan; 1():CD006640. PubMed ID: 22258969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous versus topical tranexamic acid in primary total hip replacement: A systemic review and meta-analysis.
    Sun X; Dong Q; Zhang YG
    Int J Surg; 2016 Aug; 32():10-8. PubMed ID: 27262881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined intravenous and topical tranexamic acid versus intravenous use alone in primary total knee and hip arthroplasty: A meta-analysis of randomized controlled trials.
    Shang J; Wang H; Zheng B; Rui M; Wang Y
    Int J Surg; 2016 Dec; 36(Pt A):324-329. PubMed ID: 27856355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.